Clinical Trial Update: BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BIBR 1048 in preventing venous thromboembolism in adults undergoing primary elective total hip replacement; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• BIBR 1048

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Thromboembolism | Phase 2 | Status: COMPLETED